He Dou

No.150, Haping Road, Nangang District
Harbin, 150081, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Lactate dehydrogenase a is a crucial biomarker that affects the prognosis, chemotherapy effect, and immune infiltration of breast cancer.

Lactate dehydrogenase a is a crucial biomarker that affects the prognosis, chemotherapy effect, and immune infiltration of breast cancer.

Journal: BMC women's health

Published: June 26, 2025

Triglyceride-glucose index and triglyceride-glucose-body mass index as prognostic factors for early stage breast cancer patients receiving neoadjuvant chemotherapy.

Triglyceride-glucose index and triglyceride-glucose-body mass index as prognostic factors for early stage breast cancer patients receiving neoadjuvant chemotherapy.

Journal: Translational oncology

Published: August 07, 2024

Comparison of clinical characteristics and pathologic complete response rate after neoadjuvant chemotherapy in women under 35 years and older women with breast cancer.

Comparison of clinical characteristics and pathologic complete response rate after neoadjuvant chemotherapy in women under 35 years and older women with breast cancer.

Journal: Gland surgery

Published: July 12, 2024

Association of immune inflammatory biomarkers with pathological complete response and clinical prognosis in young breast cancer patients undergoing neoadjuvant chemotherapy.

Association of immune inflammatory biomarkers with pathological complete response and clinical prognosis in young breast cancer patients undergoing neoadjuvant chemotherapy.

Journal: Frontiers in oncology

Published: December 04, 2023

Recent advances in caspase-3, breast cancer, and traditional Chinese medicine: a review.

Recent advances in caspase-3, breast cancer, and traditional Chinese medicine: a review.

Journal: Journal of chemotherapy (Florence, Italy)

Published: November 08, 2023

Estrogen receptor-negative/progesterone receptor-positive breast cancer has distinct characteristics and pathologic complete response rate after neoadjuvant chemotherapy.

Estrogen receptor-negative/progesterone receptor-positive breast cancer has distinct characteristics and pathologic complete response rate after neoadjuvant chemotherapy.

Journal: Diagnostic pathology

Published: October 09, 2023

Clinical characteristics and pathologic complete response (pCR) rate after neoadjuvant chemotherapy in postpartum women with breast cancer.

Clinical characteristics and pathologic complete response (pCR) rate after neoadjuvant chemotherapy in postpartum women with breast cancer.

Journal: Journal of cancer research and clinical oncology

Published: July 01, 2023

Vacuum-assisted biopsy system for breast lesions: a potential therapeutic approach.

Vacuum-assisted biopsy system for breast lesions: a potential therapeutic approach.

Journal: Frontiers in oncology

Published: May 28, 2023

Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments.

Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments.

Journal: Molecular cancer

Published: January 13, 2023

Breast Cancer Exosome-Derived miR-425-5p Induces Cancer-Associated Fibroblast-Like Properties in Human Mammary Fibroblasts by TGFβ1/ROS Signaling Pathway.

Breast Cancer Exosome-Derived miR-425-5p Induces Cancer-Associated Fibroblast-Like Properties in Human Mammary Fibroblasts by TGFβ1/ROS Signaling Pathway.

Journal: Oxidative medicine and cellular longevity

Published: May 24, 2022

Showing 1-10 of 10

Last Updated: 09/26/2026